Literature DB >> 8735730

Collagen and glycosaminoglycans of Wharton's jelly and their alterations in EPH-gestosis.

E Bańkowski1, K Sobolewski, L Romanowicz, L Chyczewski, S Jaworski.   

Abstract

Some prenatal pathological processes may be caused by biochemical and morphological alterations in the umbilical cord (UC). EPH-gestosis is the most common pregnancy-associated pathological process. For these reasons the role of collagen and glycos-aminoglycans (GAGs) of UC in pathobiochemistry of this syndrome seems to be important. We studied histology of extracellular matrix components, quantity, solubility and molecular polymorphism of collagen, proportional relationships between various types of collagen, the amounts of GAGs and proportional relationships between them in Wharton's jelly of control newborns delivered by healthy mothers and those delivered by mothers with EPH-gestosis. We found that Wharton's jelly is abundant in collagen and GAGs. This collagen is very insoluble and resistant to the action of depolymerizing agents (4% EDTA-Na2, pepsin). Types I, III and V collagens were isolated and quantified. Hyaluronic acid constitutes about 70%, whereas sulphated GAGs constitute about 30% of total GAGs. EPH-gestosis is accompanied by significant increase in sulphated GAGs: hyaluronic acid ratio. The EPH-gestosis-associated alterations in Wharton's jelly correspond to 'premature ageing' of this tissue.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735730     DOI: 10.1016/0301-2115(96)02390-1

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  16 in total

1.  An accumulation of IGF-I and IGF-binding proteins in human umbilical cord.

Authors:  J Pałka; E Bańikowski; S Jaworski
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

2.  Differential effect of fasting on IGF-BPs in serum of young and adult rats and its implication to impaired skin GAG content.

Authors:  M Cechowska-Pasko; J Pałka
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

3.  Mass transfer trends occurring in engineered ex vivo tissue scaffolds.

Authors:  Marc Moore; Malisa Sarntinoranont; Peter McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

4.  Determination of hyperelastic properties for umbilical artery in preeclampsia from uniaxial extension tests.

Authors:  R Blair Dodson; John T Martin; Kendall S Hunter; Virginia L Ferguson
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-03-31       Impact factor: 2.435

5.  An accumulation of proteoglycans in scarred fascia.

Authors:  E M Koźma; K Olczyk; A Głowacki; R Bobiński
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

6.  An expression of IGF-binding proteins in normal and pre-eclamptic human umbilical cord serum and tissues.

Authors:  Edward Bańkowski; Jerzy Pałka; Stefan Jaworski
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

7.  Extracellular matrix components in uterine leiomyoma and their alteration during the tumour growth.

Authors:  M Wolańska; K Sobolewski; M Drozdzewicz; E Bańkowski
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

Review 8.  Preparation of placental tissue transplants and their application in skin wound healing and chosen skin bullous diseases - Stevens-Johnson syndrome and toxic epidermal necrolysis treatment.

Authors:  Agnieszka Klama-Baryła; Ewa Rojczyk; Diana Kitala; Wojciech Łabuś; Wojciech Smętek; Katarzyna Wilemska-Kucharzewska; Marek Kucharzewski
Journal:  Int Wound J       Date:  2020-01-15       Impact factor: 3.315

Review 9.  Extracellular matrix remodeling of the umbilical cord in pre-eclampsia as a risk factor for fetal hypertension.

Authors:  Lech Romanowicz; Zofia Galewska
Journal:  J Pregnancy       Date:  2010-12-29

10.  Area of Wharton's jelly as an estimate of the thickness of the umbilical cord and its relationship with estimated fetal weight.

Authors:  Cristiane Barbieri; Jose G Cecatti; Fernanda G Surita; Maria L Costa; Emilio F Marussi; Jose V Costa
Journal:  Reprod Health       Date:  2011-11-04       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.